24 May 2013
Keywords: sipaco, orlaam, approved, emea, european, medicines, evaluation
Article | 07 August 1997
The European Medicines Evaluation Agency has approved SipacoInternacional of Portugal's application to market Orlaam (levacetylmethadol) for the maintenance treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.